Amgen Inc. has released its unaudited financial results for the second quarter of 2025, detailing the company's operational performance for the period ending June 30, 2025. This disclosure is critical for investors as it provides essential updates on the company's profitability, operating margins, and free cash flow to evaluate its current financial health and growth trajectory.
